Cargando…
Disrupting the MAD2L2-Rev1 Complex Enhances Cell Death upon DNA Damage
DNA-damaging chemotherapy agents such as cisplatin have been the first line of treatment for cancer for decades. While chemotherapy can be very effective, its long-term success is often reduced by intrinsic and acquired drug resistance, accompanied by chemotherapy-resistant secondary malignancies. A...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8838411/ https://www.ncbi.nlm.nih.gov/pubmed/35163901 http://dx.doi.org/10.3390/molecules27030636 |